Global Choroidal Neovascularization Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Choroidal Neovascularization market size was valued at US$ million in 2023. With growing demand in downstream market, the Choroidal Neovascularization is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Choroidal Neovascularization market. Choroidal Neovascularization are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Choroidal Neovascularization. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Choroidal Neovascularization market.
Choroidal neovascularization describes the growth of new blood vessels that originate from the choroid through a break in the Bruch membrane into the sub–retinal pigment epithelium (sub-RPE) or subretinal space.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on Choroidal Neovascularization market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Choroidal Neovascularization market. It may include historical data, market segmentation by Type (e.g., Intravenous, Intravitreal), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Choroidal Neovascularization market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Choroidal Neovascularization market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Choroidal Neovascularization industry. This include advancements in Choroidal Neovascularization technology, Choroidal Neovascularization new entrants, Choroidal Neovascularization new investment, and other innovations that are shaping the future of Choroidal Neovascularization.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Choroidal Neovascularization market. It includes factors influencing customer ' purchasing decisions, preferences for Choroidal Neovascularization product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Choroidal Neovascularization market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Choroidal Neovascularization market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Choroidal Neovascularization market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Choroidal Neovascularization industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Choroidal Neovascularization market.
Market Segmentation:
Choroidal Neovascularization market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Choroidal Neovascularization market?
What factors are driving Choroidal Neovascularization market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Choroidal Neovascularization market opportunities vary by end market size?
How does Choroidal Neovascularization break out type, application?
According to our LPI (LP Information) latest study, the global Choroidal Neovascularization market size was valued at US$ million in 2023. With growing demand in downstream market, the Choroidal Neovascularization is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Choroidal Neovascularization market. Choroidal Neovascularization are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Choroidal Neovascularization. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Choroidal Neovascularization market.
Choroidal neovascularization describes the growth of new blood vessels that originate from the choroid through a break in the Bruch membrane into the sub–retinal pigment epithelium (sub-RPE) or subretinal space.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on Choroidal Neovascularization market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Choroidal Neovascularization market. It may include historical data, market segmentation by Type (e.g., Intravenous, Intravitreal), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Choroidal Neovascularization market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Choroidal Neovascularization market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Choroidal Neovascularization industry. This include advancements in Choroidal Neovascularization technology, Choroidal Neovascularization new entrants, Choroidal Neovascularization new investment, and other innovations that are shaping the future of Choroidal Neovascularization.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Choroidal Neovascularization market. It includes factors influencing customer ' purchasing decisions, preferences for Choroidal Neovascularization product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Choroidal Neovascularization market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Choroidal Neovascularization market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Choroidal Neovascularization market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Choroidal Neovascularization industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Choroidal Neovascularization market.
Market Segmentation:
Choroidal Neovascularization market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Intravenous
- Intravitreal
- Extreme Myopia
- Malignant Myopic Degeneration
- Age-Related Developments
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer Inc.
- F. Hoffmann-La Roche Ltd.
- Novartis AG
- Regeneron Pharmaceuticals Inc.
- Bayer AG
- QLT Inc.
- Sanwa Kagaku Kenkyusho Co. Ltd.
- Promedior Inc.
- Bausch Health
- Gilead Sciences Inc
What is the 10-year outlook for the global Choroidal Neovascularization market?
What factors are driving Choroidal Neovascularization market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Choroidal Neovascularization market opportunities vary by end market size?
How does Choroidal Neovascularization break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Choroidal Neovascularization Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Choroidal Neovascularization by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Choroidal Neovascularization by Country/Region, 2019, 2023 & 2030
2.2 Choroidal Neovascularization Segment by Type
2.2.1 Intravenous
2.2.2 Intravitreal
2.3 Choroidal Neovascularization Sales by Type
2.3.1 Global Choroidal Neovascularization Sales Market Share by Type (2019-2024)
2.3.2 Global Choroidal Neovascularization Revenue and Market Share by Type (2019-2024)
2.3.3 Global Choroidal Neovascularization Sale Price by Type (2019-2024)
2.4 Choroidal Neovascularization Segment by Application
2.4.1 Extreme Myopia
2.4.2 Malignant Myopic Degeneration
2.4.3 Age-Related Developments
2.5 Choroidal Neovascularization Sales by Application
2.5.1 Global Choroidal Neovascularization Sale Market Share by Application (2019-2024)
2.5.2 Global Choroidal Neovascularization Revenue and Market Share by Application (2019-2024)
2.5.3 Global Choroidal Neovascularization Sale Price by Application (2019-2024)
3 GLOBAL CHOROIDAL NEOVASCULARIZATION BY COMPANY
3.1 Global Choroidal Neovascularization Breakdown Data by Company
3.1.1 Global Choroidal Neovascularization Annual Sales by Company (2019-2024)
3.1.2 Global Choroidal Neovascularization Sales Market Share by Company (2019-2024)
3.2 Global Choroidal Neovascularization Annual Revenue by Company (2019-2024)
3.2.1 Global Choroidal Neovascularization Revenue by Company (2019-2024)
3.2.2 Global Choroidal Neovascularization Revenue Market Share by Company (2019-2024)
3.3 Global Choroidal Neovascularization Sale Price by Company
3.4 Key Manufacturers Choroidal Neovascularization Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Choroidal Neovascularization Product Location Distribution
3.4.2 Players Choroidal Neovascularization Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR CHOROIDAL NEOVASCULARIZATION BY GEOGRAPHIC REGION
4.1 World Historic Choroidal Neovascularization Market Size by Geographic Region (2019-2024)
4.1.1 Global Choroidal Neovascularization Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Choroidal Neovascularization Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Choroidal Neovascularization Market Size by Country/Region (2019-2024)
4.2.1 Global Choroidal Neovascularization Annual Sales by Country/Region (2019-2024)
4.2.2 Global Choroidal Neovascularization Annual Revenue by Country/Region (2019-2024)
4.3 Americas Choroidal Neovascularization Sales Growth
4.4 APAC Choroidal Neovascularization Sales Growth
4.5 Europe Choroidal Neovascularization Sales Growth
4.6 Middle East & Africa Choroidal Neovascularization Sales Growth
5 AMERICAS
5.1 Americas Choroidal Neovascularization Sales by Country
5.1.1 Americas Choroidal Neovascularization Sales by Country (2019-2024)
5.1.2 Americas Choroidal Neovascularization Revenue by Country (2019-2024)
5.2 Americas Choroidal Neovascularization Sales by Type
5.3 Americas Choroidal Neovascularization Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Choroidal Neovascularization Sales by Region
6.1.1 APAC Choroidal Neovascularization Sales by Region (2019-2024)
6.1.2 APAC Choroidal Neovascularization Revenue by Region (2019-2024)
6.2 APAC Choroidal Neovascularization Sales by Type
6.3 APAC Choroidal Neovascularization Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Choroidal Neovascularization by Country
7.1.1 Europe Choroidal Neovascularization Sales by Country (2019-2024)
7.1.2 Europe Choroidal Neovascularization Revenue by Country (2019-2024)
7.2 Europe Choroidal Neovascularization Sales by Type
7.3 Europe Choroidal Neovascularization Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Choroidal Neovascularization by Country
8.1.1 Middle East & Africa Choroidal Neovascularization Sales by Country (2019-2024)
8.1.2 Middle East & Africa Choroidal Neovascularization Revenue by Country (2019-2024)
8.2 Middle East & Africa Choroidal Neovascularization Sales by Type
8.3 Middle East & Africa Choroidal Neovascularization Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Choroidal Neovascularization
10.3 Manufacturing Process Analysis of Choroidal Neovascularization
10.4 Industry Chain Structure of Choroidal Neovascularization
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Choroidal Neovascularization Distributors
11.3 Choroidal Neovascularization Customer
12 WORLD FORECAST REVIEW FOR CHOROIDAL NEOVASCULARIZATION BY GEOGRAPHIC REGION
12.1 Global Choroidal Neovascularization Market Size Forecast by Region
12.1.1 Global Choroidal Neovascularization Forecast by Region (2025-2030)
12.1.2 Global Choroidal Neovascularization Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Choroidal Neovascularization Forecast by Type
12.7 Global Choroidal Neovascularization Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Pfizer Inc.
13.1.1 Pfizer Inc. Company Information
13.1.2 Pfizer Inc. Choroidal Neovascularization Product Portfolios and Specifications
13.1.3 Pfizer Inc. Choroidal Neovascularization Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Pfizer Inc. Main Business Overview
13.1.5 Pfizer Inc. Latest Developments
13.2 F. Hoffmann-La Roche Ltd.
13.2.1 F. Hoffmann-La Roche Ltd. Company Information
13.2.2 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Product Portfolios and Specifications
13.2.3 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 F. Hoffmann-La Roche Ltd. Main Business Overview
13.2.5 F. Hoffmann-La Roche Ltd. Latest Developments
13.3 Novartis AG
13.3.1 Novartis AG Company Information
13.3.2 Novartis AG Choroidal Neovascularization Product Portfolios and Specifications
13.3.3 Novartis AG Choroidal Neovascularization Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Novartis AG Main Business Overview
13.3.5 Novartis AG Latest Developments
13.4 Regeneron Pharmaceuticals Inc.
13.4.1 Regeneron Pharmaceuticals Inc. Company Information
13.4.2 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Product Portfolios and Specifications
13.4.3 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Regeneron Pharmaceuticals Inc. Main Business Overview
13.4.5 Regeneron Pharmaceuticals Inc. Latest Developments
13.5 Bayer AG
13.5.1 Bayer AG Company Information
13.5.2 Bayer AG Choroidal Neovascularization Product Portfolios and Specifications
13.5.3 Bayer AG Choroidal Neovascularization Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Bayer AG Main Business Overview
13.5.5 Bayer AG Latest Developments
13.6 QLT Inc.
13.6.1 QLT Inc. Company Information
13.6.2 QLT Inc. Choroidal Neovascularization Product Portfolios and Specifications
13.6.3 QLT Inc. Choroidal Neovascularization Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 QLT Inc. Main Business Overview
13.6.5 QLT Inc. Latest Developments
13.7 Sanwa Kagaku Kenkyusho Co. Ltd.
13.7.1 Sanwa Kagaku Kenkyusho Co. Ltd. Company Information
13.7.2 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Product Portfolios and Specifications
13.7.3 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Sanwa Kagaku Kenkyusho Co. Ltd. Main Business Overview
13.7.5 Sanwa Kagaku Kenkyusho Co. Ltd. Latest Developments
13.8 Promedior Inc.
13.8.1 Promedior Inc. Company Information
13.8.2 Promedior Inc. Choroidal Neovascularization Product Portfolios and Specifications
13.8.3 Promedior Inc. Choroidal Neovascularization Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Promedior Inc. Main Business Overview
13.8.5 Promedior Inc. Latest Developments
13.9 Bausch Health
13.9.1 Bausch Health Company Information
13.9.2 Bausch Health Choroidal Neovascularization Product Portfolios and Specifications
13.9.3 Bausch Health Choroidal Neovascularization Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Bausch Health Main Business Overview
13.9.5 Bausch Health Latest Developments
13.10 Gilead Sciences Inc
13.10.1 Gilead Sciences Inc Company Information
13.10.2 Gilead Sciences Inc Choroidal Neovascularization Product Portfolios and Specifications
13.10.3 Gilead Sciences Inc Choroidal Neovascularization Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Gilead Sciences Inc Main Business Overview
13.10.5 Gilead Sciences Inc Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Choroidal Neovascularization Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Choroidal Neovascularization by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Choroidal Neovascularization by Country/Region, 2019, 2023 & 2030
2.2 Choroidal Neovascularization Segment by Type
2.2.1 Intravenous
2.2.2 Intravitreal
2.3 Choroidal Neovascularization Sales by Type
2.3.1 Global Choroidal Neovascularization Sales Market Share by Type (2019-2024)
2.3.2 Global Choroidal Neovascularization Revenue and Market Share by Type (2019-2024)
2.3.3 Global Choroidal Neovascularization Sale Price by Type (2019-2024)
2.4 Choroidal Neovascularization Segment by Application
2.4.1 Extreme Myopia
2.4.2 Malignant Myopic Degeneration
2.4.3 Age-Related Developments
2.5 Choroidal Neovascularization Sales by Application
2.5.1 Global Choroidal Neovascularization Sale Market Share by Application (2019-2024)
2.5.2 Global Choroidal Neovascularization Revenue and Market Share by Application (2019-2024)
2.5.3 Global Choroidal Neovascularization Sale Price by Application (2019-2024)
3 GLOBAL CHOROIDAL NEOVASCULARIZATION BY COMPANY
3.1 Global Choroidal Neovascularization Breakdown Data by Company
3.1.1 Global Choroidal Neovascularization Annual Sales by Company (2019-2024)
3.1.2 Global Choroidal Neovascularization Sales Market Share by Company (2019-2024)
3.2 Global Choroidal Neovascularization Annual Revenue by Company (2019-2024)
3.2.1 Global Choroidal Neovascularization Revenue by Company (2019-2024)
3.2.2 Global Choroidal Neovascularization Revenue Market Share by Company (2019-2024)
3.3 Global Choroidal Neovascularization Sale Price by Company
3.4 Key Manufacturers Choroidal Neovascularization Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Choroidal Neovascularization Product Location Distribution
3.4.2 Players Choroidal Neovascularization Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR CHOROIDAL NEOVASCULARIZATION BY GEOGRAPHIC REGION
4.1 World Historic Choroidal Neovascularization Market Size by Geographic Region (2019-2024)
4.1.1 Global Choroidal Neovascularization Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Choroidal Neovascularization Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Choroidal Neovascularization Market Size by Country/Region (2019-2024)
4.2.1 Global Choroidal Neovascularization Annual Sales by Country/Region (2019-2024)
4.2.2 Global Choroidal Neovascularization Annual Revenue by Country/Region (2019-2024)
4.3 Americas Choroidal Neovascularization Sales Growth
4.4 APAC Choroidal Neovascularization Sales Growth
4.5 Europe Choroidal Neovascularization Sales Growth
4.6 Middle East & Africa Choroidal Neovascularization Sales Growth
5 AMERICAS
5.1 Americas Choroidal Neovascularization Sales by Country
5.1.1 Americas Choroidal Neovascularization Sales by Country (2019-2024)
5.1.2 Americas Choroidal Neovascularization Revenue by Country (2019-2024)
5.2 Americas Choroidal Neovascularization Sales by Type
5.3 Americas Choroidal Neovascularization Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Choroidal Neovascularization Sales by Region
6.1.1 APAC Choroidal Neovascularization Sales by Region (2019-2024)
6.1.2 APAC Choroidal Neovascularization Revenue by Region (2019-2024)
6.2 APAC Choroidal Neovascularization Sales by Type
6.3 APAC Choroidal Neovascularization Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Choroidal Neovascularization by Country
7.1.1 Europe Choroidal Neovascularization Sales by Country (2019-2024)
7.1.2 Europe Choroidal Neovascularization Revenue by Country (2019-2024)
7.2 Europe Choroidal Neovascularization Sales by Type
7.3 Europe Choroidal Neovascularization Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Choroidal Neovascularization by Country
8.1.1 Middle East & Africa Choroidal Neovascularization Sales by Country (2019-2024)
8.1.2 Middle East & Africa Choroidal Neovascularization Revenue by Country (2019-2024)
8.2 Middle East & Africa Choroidal Neovascularization Sales by Type
8.3 Middle East & Africa Choroidal Neovascularization Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Choroidal Neovascularization
10.3 Manufacturing Process Analysis of Choroidal Neovascularization
10.4 Industry Chain Structure of Choroidal Neovascularization
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Choroidal Neovascularization Distributors
11.3 Choroidal Neovascularization Customer
12 WORLD FORECAST REVIEW FOR CHOROIDAL NEOVASCULARIZATION BY GEOGRAPHIC REGION
12.1 Global Choroidal Neovascularization Market Size Forecast by Region
12.1.1 Global Choroidal Neovascularization Forecast by Region (2025-2030)
12.1.2 Global Choroidal Neovascularization Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Choroidal Neovascularization Forecast by Type
12.7 Global Choroidal Neovascularization Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Pfizer Inc.
13.1.1 Pfizer Inc. Company Information
13.1.2 Pfizer Inc. Choroidal Neovascularization Product Portfolios and Specifications
13.1.3 Pfizer Inc. Choroidal Neovascularization Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Pfizer Inc. Main Business Overview
13.1.5 Pfizer Inc. Latest Developments
13.2 F. Hoffmann-La Roche Ltd.
13.2.1 F. Hoffmann-La Roche Ltd. Company Information
13.2.2 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Product Portfolios and Specifications
13.2.3 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 F. Hoffmann-La Roche Ltd. Main Business Overview
13.2.5 F. Hoffmann-La Roche Ltd. Latest Developments
13.3 Novartis AG
13.3.1 Novartis AG Company Information
13.3.2 Novartis AG Choroidal Neovascularization Product Portfolios and Specifications
13.3.3 Novartis AG Choroidal Neovascularization Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Novartis AG Main Business Overview
13.3.5 Novartis AG Latest Developments
13.4 Regeneron Pharmaceuticals Inc.
13.4.1 Regeneron Pharmaceuticals Inc. Company Information
13.4.2 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Product Portfolios and Specifications
13.4.3 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Regeneron Pharmaceuticals Inc. Main Business Overview
13.4.5 Regeneron Pharmaceuticals Inc. Latest Developments
13.5 Bayer AG
13.5.1 Bayer AG Company Information
13.5.2 Bayer AG Choroidal Neovascularization Product Portfolios and Specifications
13.5.3 Bayer AG Choroidal Neovascularization Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Bayer AG Main Business Overview
13.5.5 Bayer AG Latest Developments
13.6 QLT Inc.
13.6.1 QLT Inc. Company Information
13.6.2 QLT Inc. Choroidal Neovascularization Product Portfolios and Specifications
13.6.3 QLT Inc. Choroidal Neovascularization Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 QLT Inc. Main Business Overview
13.6.5 QLT Inc. Latest Developments
13.7 Sanwa Kagaku Kenkyusho Co. Ltd.
13.7.1 Sanwa Kagaku Kenkyusho Co. Ltd. Company Information
13.7.2 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Product Portfolios and Specifications
13.7.3 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Sanwa Kagaku Kenkyusho Co. Ltd. Main Business Overview
13.7.5 Sanwa Kagaku Kenkyusho Co. Ltd. Latest Developments
13.8 Promedior Inc.
13.8.1 Promedior Inc. Company Information
13.8.2 Promedior Inc. Choroidal Neovascularization Product Portfolios and Specifications
13.8.3 Promedior Inc. Choroidal Neovascularization Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Promedior Inc. Main Business Overview
13.8.5 Promedior Inc. Latest Developments
13.9 Bausch Health
13.9.1 Bausch Health Company Information
13.9.2 Bausch Health Choroidal Neovascularization Product Portfolios and Specifications
13.9.3 Bausch Health Choroidal Neovascularization Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Bausch Health Main Business Overview
13.9.5 Bausch Health Latest Developments
13.10 Gilead Sciences Inc
13.10.1 Gilead Sciences Inc Company Information
13.10.2 Gilead Sciences Inc Choroidal Neovascularization Product Portfolios and Specifications
13.10.3 Gilead Sciences Inc Choroidal Neovascularization Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Gilead Sciences Inc Main Business Overview
13.10.5 Gilead Sciences Inc Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Choroidal Neovascularization Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Choroidal Neovascularization Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Intravenous
Table 4. Major Players of Intravitreal
Table 5. Global Choroidal Neovascularization Sales by Type (2019-2024) & (K Units)
Table 6. Global Choroidal Neovascularization Sales Market Share by Type (2019-2024)
Table 7. Global Choroidal Neovascularization Revenue by Type (2019-2024) & ($ million)
Table 8. Global Choroidal Neovascularization Revenue Market Share by Type (2019-2024)
Table 9. Global Choroidal Neovascularization Sale Price by Type (2019-2024) & (USD/Unit)
Table 10. Global Choroidal Neovascularization Sales by Application (2019-2024) & (K Units)
Table 11. Global Choroidal Neovascularization Sales Market Share by Application (2019-2024)
Table 12. Global Choroidal Neovascularization Revenue by Application (2019-2024)
Table 13. Global Choroidal Neovascularization Revenue Market Share by Application (2019-2024)
Table 14. Global Choroidal Neovascularization Sale Price by Application (2019-2024) & (USD/Unit)
Table 15. Global Choroidal Neovascularization Sales by Company (2019-2024) & (K Units)
Table 16. Global Choroidal Neovascularization Sales Market Share by Company (2019-2024)
Table 17. Global Choroidal Neovascularization Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Choroidal Neovascularization Revenue Market Share by Company (2019-2024)
Table 19. Global Choroidal Neovascularization Sale Price by Company (2019-2024) & (USD/Unit)
Table 20. Key Manufacturers Choroidal Neovascularization Producing Area Distribution and Sales Area
Table 21. Players Choroidal Neovascularization Products Offered
Table 22. Choroidal Neovascularization Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Choroidal Neovascularization Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Choroidal Neovascularization Sales Market Share Geographic Region (2019-2024)
Table 27. Global Choroidal Neovascularization Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Choroidal Neovascularization Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Choroidal Neovascularization Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Choroidal Neovascularization Sales Market Share by Country/Region (2019-2024)
Table 31. Global Choroidal Neovascularization Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Choroidal Neovascularization Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Choroidal Neovascularization Sales by Country (2019-2024) & (K Units)
Table 34. Americas Choroidal Neovascularization Sales Market Share by Country (2019-2024)
Table 35. Americas Choroidal Neovascularization Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Choroidal Neovascularization Revenue Market Share by Country (2019-2024)
Table 37. Americas Choroidal Neovascularization Sales by Type (2019-2024) & (K Units)
Table 38. Americas Choroidal Neovascularization Sales by Application (2019-2024) & (K Units)
Table 39. APAC Choroidal Neovascularization Sales by Region (2019-2024) & (K Units)
Table 40. APAC Choroidal Neovascularization Sales Market Share by Region (2019-2024)
Table 41. APAC Choroidal Neovascularization Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Choroidal Neovascularization Revenue Market Share by Region (2019-2024)
Table 43. APAC Choroidal Neovascularization Sales by Type (2019-2024) & (K Units)
Table 44. APAC Choroidal Neovascularization Sales by Application (2019-2024) & (K Units)
Table 45. Europe Choroidal Neovascularization Sales by Country (2019-2024) & (K Units)
Table 46. Europe Choroidal Neovascularization Sales Market Share by Country (2019-2024)
Table 47. Europe Choroidal Neovascularization Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Choroidal Neovascularization Revenue Market Share by Country (2019-2024)
Table 49. Europe Choroidal Neovascularization Sales by Type (2019-2024) & (K Units)
Table 50. Europe Choroidal Neovascularization Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Choroidal Neovascularization Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Choroidal Neovascularization Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Choroidal Neovascularization Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Choroidal Neovascularization Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Choroidal Neovascularization Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Choroidal Neovascularization Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Choroidal Neovascularization
Table 58. Key Market Challenges & Risks of Choroidal Neovascularization
Table 59. Key Industry Trends of Choroidal Neovascularization
Table 60. Choroidal Neovascularization Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Choroidal Neovascularization Distributors List
Table 63. Choroidal Neovascularization Customer List
Table 64. Global Choroidal Neovascularization Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Choroidal Neovascularization Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Choroidal Neovascularization Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Choroidal Neovascularization Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Choroidal Neovascularization Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Choroidal Neovascularization Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Choroidal Neovascularization Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Choroidal Neovascularization Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Choroidal Neovascularization Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Choroidal Neovascularization Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Choroidal Neovascularization Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Choroidal Neovascularization Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Choroidal Neovascularization Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Choroidal Neovascularization Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Pfizer Inc. Basic Information, Choroidal Neovascularization Manufacturing Base, Sales Area and Its Competitors
Table 79. Pfizer Inc. Choroidal Neovascularization Product Portfolios and Specifications
Table 80. Pfizer Inc. Choroidal Neovascularization Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 81. Pfizer Inc. Main Business
Table 82. Pfizer Inc. Latest Developments
Table 83. F. Hoffmann-La Roche Ltd. Basic Information, Choroidal Neovascularization Manufacturing Base, Sales Area and Its Competitors
Table 84. F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Product Portfolios and Specifications
Table 85. F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 86. F. Hoffmann-La Roche Ltd. Main Business
Table 87. F. Hoffmann-La Roche Ltd. Latest Developments
Table 88. Novartis AG Basic Information, Choroidal Neovascularization Manufacturing Base, Sales Area and Its Competitors
Table 89. Novartis AG Choroidal Neovascularization Product Portfolios and Specifications
Table 90. Novartis AG Choroidal Neovascularization Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 91. Novartis AG Main Business
Table 92. Novartis AG Latest Developments
Table 93. Regeneron Pharmaceuticals Inc. Basic Information, Choroidal Neovascularization Manufacturing Base, Sales Area and Its Competitors
Table 94. Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Product Portfolios and Specifications
Table 95. Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 96. Regeneron Pharmaceuticals Inc. Main Business
Table 97. Regeneron Pharmaceuticals Inc. Latest Developments
Table 98. Bayer AG Basic Information, Choroidal Neovascularization Manufacturing Base, Sales Area and Its Competitors
Table 99. Bayer AG Choroidal Neovascularization Product Portfolios and Specifications
Table 100. Bayer AG Choroidal Neovascularization Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 101. Bayer AG Main Business
Table 102. Bayer AG Latest Developments
Table 103. QLT Inc. Basic Information, Choroidal Neovascularization Manufacturing Base, Sales Area and Its Competitors
Table 104. QLT Inc. Choroidal Neovascularization Product Portfolios and Specifications
Table 105. QLT Inc. Choroidal Neovascularization Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 106. QLT Inc. Main Business
Table 107. QLT Inc. Latest Developments
Table 108. Sanwa Kagaku Kenkyusho Co. Ltd. Basic Information, Choroidal Neovascularization Manufacturing Base, Sales Area and Its Competitors
Table 109. Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Product Portfolios and Specifications
Table 110. Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 111. Sanwa Kagaku Kenkyusho Co. Ltd. Main Business
Table 112. Sanwa Kagaku Kenkyusho Co. Ltd. Latest Developments
Table 113. Promedior Inc. Basic Information, Choroidal Neovascularization Manufacturing Base, Sales Area and Its Competitors
Table 114. Promedior Inc. Choroidal Neovascularization Product Portfolios and Specifications
Table 115. Promedior Inc. Choroidal Neovascularization Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 116. Promedior Inc. Main Business
Table 117. Promedior Inc. Latest Developments
Table 118. Bausch Health Basic Information, Choroidal Neovascularization Manufacturing Base, Sales Area and Its Competitors
Table 119. Bausch Health Choroidal Neovascularization Product Portfolios and Specifications
Table 120. Bausch Health Choroidal Neovascularization Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 121. Bausch Health Main Business
Table 122. Bausch Health Latest Developments
Table 123. Gilead Sciences Inc Basic Information, Choroidal Neovascularization Manufacturing Base, Sales Area and Its Competitors
Table 124. Gilead Sciences Inc Choroidal Neovascularization Product Portfolios and Specifications
Table 125. Gilead Sciences Inc Choroidal Neovascularization Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 126. Gilead Sciences Inc Main Business
Table 127. Gilead Sciences Inc Latest Developments
Table 1. Choroidal Neovascularization Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Choroidal Neovascularization Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Intravenous
Table 4. Major Players of Intravitreal
Table 5. Global Choroidal Neovascularization Sales by Type (2019-2024) & (K Units)
Table 6. Global Choroidal Neovascularization Sales Market Share by Type (2019-2024)
Table 7. Global Choroidal Neovascularization Revenue by Type (2019-2024) & ($ million)
Table 8. Global Choroidal Neovascularization Revenue Market Share by Type (2019-2024)
Table 9. Global Choroidal Neovascularization Sale Price by Type (2019-2024) & (USD/Unit)
Table 10. Global Choroidal Neovascularization Sales by Application (2019-2024) & (K Units)
Table 11. Global Choroidal Neovascularization Sales Market Share by Application (2019-2024)
Table 12. Global Choroidal Neovascularization Revenue by Application (2019-2024)
Table 13. Global Choroidal Neovascularization Revenue Market Share by Application (2019-2024)
Table 14. Global Choroidal Neovascularization Sale Price by Application (2019-2024) & (USD/Unit)
Table 15. Global Choroidal Neovascularization Sales by Company (2019-2024) & (K Units)
Table 16. Global Choroidal Neovascularization Sales Market Share by Company (2019-2024)
Table 17. Global Choroidal Neovascularization Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Choroidal Neovascularization Revenue Market Share by Company (2019-2024)
Table 19. Global Choroidal Neovascularization Sale Price by Company (2019-2024) & (USD/Unit)
Table 20. Key Manufacturers Choroidal Neovascularization Producing Area Distribution and Sales Area
Table 21. Players Choroidal Neovascularization Products Offered
Table 22. Choroidal Neovascularization Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Choroidal Neovascularization Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Choroidal Neovascularization Sales Market Share Geographic Region (2019-2024)
Table 27. Global Choroidal Neovascularization Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Choroidal Neovascularization Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Choroidal Neovascularization Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Choroidal Neovascularization Sales Market Share by Country/Region (2019-2024)
Table 31. Global Choroidal Neovascularization Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Choroidal Neovascularization Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Choroidal Neovascularization Sales by Country (2019-2024) & (K Units)
Table 34. Americas Choroidal Neovascularization Sales Market Share by Country (2019-2024)
Table 35. Americas Choroidal Neovascularization Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Choroidal Neovascularization Revenue Market Share by Country (2019-2024)
Table 37. Americas Choroidal Neovascularization Sales by Type (2019-2024) & (K Units)
Table 38. Americas Choroidal Neovascularization Sales by Application (2019-2024) & (K Units)
Table 39. APAC Choroidal Neovascularization Sales by Region (2019-2024) & (K Units)
Table 40. APAC Choroidal Neovascularization Sales Market Share by Region (2019-2024)
Table 41. APAC Choroidal Neovascularization Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Choroidal Neovascularization Revenue Market Share by Region (2019-2024)
Table 43. APAC Choroidal Neovascularization Sales by Type (2019-2024) & (K Units)
Table 44. APAC Choroidal Neovascularization Sales by Application (2019-2024) & (K Units)
Table 45. Europe Choroidal Neovascularization Sales by Country (2019-2024) & (K Units)
Table 46. Europe Choroidal Neovascularization Sales Market Share by Country (2019-2024)
Table 47. Europe Choroidal Neovascularization Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Choroidal Neovascularization Revenue Market Share by Country (2019-2024)
Table 49. Europe Choroidal Neovascularization Sales by Type (2019-2024) & (K Units)
Table 50. Europe Choroidal Neovascularization Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Choroidal Neovascularization Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Choroidal Neovascularization Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Choroidal Neovascularization Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Choroidal Neovascularization Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Choroidal Neovascularization Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Choroidal Neovascularization Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Choroidal Neovascularization
Table 58. Key Market Challenges & Risks of Choroidal Neovascularization
Table 59. Key Industry Trends of Choroidal Neovascularization
Table 60. Choroidal Neovascularization Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Choroidal Neovascularization Distributors List
Table 63. Choroidal Neovascularization Customer List
Table 64. Global Choroidal Neovascularization Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Choroidal Neovascularization Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Choroidal Neovascularization Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Choroidal Neovascularization Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Choroidal Neovascularization Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Choroidal Neovascularization Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Choroidal Neovascularization Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Choroidal Neovascularization Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Choroidal Neovascularization Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Choroidal Neovascularization Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Choroidal Neovascularization Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Choroidal Neovascularization Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Choroidal Neovascularization Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Choroidal Neovascularization Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Pfizer Inc. Basic Information, Choroidal Neovascularization Manufacturing Base, Sales Area and Its Competitors
Table 79. Pfizer Inc. Choroidal Neovascularization Product Portfolios and Specifications
Table 80. Pfizer Inc. Choroidal Neovascularization Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 81. Pfizer Inc. Main Business
Table 82. Pfizer Inc. Latest Developments
Table 83. F. Hoffmann-La Roche Ltd. Basic Information, Choroidal Neovascularization Manufacturing Base, Sales Area and Its Competitors
Table 84. F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Product Portfolios and Specifications
Table 85. F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 86. F. Hoffmann-La Roche Ltd. Main Business
Table 87. F. Hoffmann-La Roche Ltd. Latest Developments
Table 88. Novartis AG Basic Information, Choroidal Neovascularization Manufacturing Base, Sales Area and Its Competitors
Table 89. Novartis AG Choroidal Neovascularization Product Portfolios and Specifications
Table 90. Novartis AG Choroidal Neovascularization Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 91. Novartis AG Main Business
Table 92. Novartis AG Latest Developments
Table 93. Regeneron Pharmaceuticals Inc. Basic Information, Choroidal Neovascularization Manufacturing Base, Sales Area and Its Competitors
Table 94. Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Product Portfolios and Specifications
Table 95. Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 96. Regeneron Pharmaceuticals Inc. Main Business
Table 97. Regeneron Pharmaceuticals Inc. Latest Developments
Table 98. Bayer AG Basic Information, Choroidal Neovascularization Manufacturing Base, Sales Area and Its Competitors
Table 99. Bayer AG Choroidal Neovascularization Product Portfolios and Specifications
Table 100. Bayer AG Choroidal Neovascularization Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 101. Bayer AG Main Business
Table 102. Bayer AG Latest Developments
Table 103. QLT Inc. Basic Information, Choroidal Neovascularization Manufacturing Base, Sales Area and Its Competitors
Table 104. QLT Inc. Choroidal Neovascularization Product Portfolios and Specifications
Table 105. QLT Inc. Choroidal Neovascularization Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 106. QLT Inc. Main Business
Table 107. QLT Inc. Latest Developments
Table 108. Sanwa Kagaku Kenkyusho Co. Ltd. Basic Information, Choroidal Neovascularization Manufacturing Base, Sales Area and Its Competitors
Table 109. Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Product Portfolios and Specifications
Table 110. Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 111. Sanwa Kagaku Kenkyusho Co. Ltd. Main Business
Table 112. Sanwa Kagaku Kenkyusho Co. Ltd. Latest Developments
Table 113. Promedior Inc. Basic Information, Choroidal Neovascularization Manufacturing Base, Sales Area and Its Competitors
Table 114. Promedior Inc. Choroidal Neovascularization Product Portfolios and Specifications
Table 115. Promedior Inc. Choroidal Neovascularization Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 116. Promedior Inc. Main Business
Table 117. Promedior Inc. Latest Developments
Table 118. Bausch Health Basic Information, Choroidal Neovascularization Manufacturing Base, Sales Area and Its Competitors
Table 119. Bausch Health Choroidal Neovascularization Product Portfolios and Specifications
Table 120. Bausch Health Choroidal Neovascularization Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 121. Bausch Health Main Business
Table 122. Bausch Health Latest Developments
Table 123. Gilead Sciences Inc Basic Information, Choroidal Neovascularization Manufacturing Base, Sales Area and Its Competitors
Table 124. Gilead Sciences Inc Choroidal Neovascularization Product Portfolios and Specifications
Table 125. Gilead Sciences Inc Choroidal Neovascularization Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 126. Gilead Sciences Inc Main Business
Table 127. Gilead Sciences Inc Latest Developments
LIST OF FIGURES
Figure 1. Picture of Choroidal Neovascularization
Figure 2. Choroidal Neovascularization Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Choroidal Neovascularization Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Choroidal Neovascularization Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Choroidal Neovascularization Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Intravenous
Figure 10. Product Picture of Intravitreal
Figure 11. Global Choroidal Neovascularization Sales Market Share by Type in 2023
Figure 12. Global Choroidal Neovascularization Revenue Market Share by Type (2019-2024)
Figure 13. Choroidal Neovascularization Consumed in Extreme Myopia
Figure 14. Global Choroidal Neovascularization Market: Extreme Myopia (2019-2024) & (K Units)
Figure 15. Choroidal Neovascularization Consumed in Malignant Myopic Degeneration
Figure 16. Global Choroidal Neovascularization Market: Malignant Myopic Degeneration (2019-2024) & (K Units)
Figure 17. Choroidal Neovascularization Consumed in Age-Related Developments
Figure 18. Global Choroidal Neovascularization Market: Age-Related Developments (2019-2024) & (K Units)
Figure 19. Global Choroidal Neovascularization Sales Market Share by Application (2023)
Figure 20. Global Choroidal Neovascularization Revenue Market Share by Application in 2023
Figure 21. Choroidal Neovascularization Sales Market by Company in 2023 (K Units)
Figure 22. Global Choroidal Neovascularization Sales Market Share by Company in 2023
Figure 23. Choroidal Neovascularization Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Choroidal Neovascularization Revenue Market Share by Company in 2023
Figure 25. Global Choroidal Neovascularization Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Choroidal Neovascularization Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Choroidal Neovascularization Sales 2019-2024 (K Units)
Figure 28. Americas Choroidal Neovascularization Revenue 2019-2024 ($ Millions)
Figure 29. APAC Choroidal Neovascularization Sales 2019-2024 (K Units)
Figure 30. APAC Choroidal Neovascularization Revenue 2019-2024 ($ Millions)
Figure 31. Europe Choroidal Neovascularization Sales 2019-2024 (K Units)
Figure 32. Europe Choroidal Neovascularization Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Choroidal Neovascularization Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Choroidal Neovascularization Revenue 2019-2024 ($ Millions)
Figure 35. Americas Choroidal Neovascularization Sales Market Share by Country in 2023
Figure 36. Americas Choroidal Neovascularization Revenue Market Share by Country in 2023
Figure 37. Americas Choroidal Neovascularization Sales Market Share by Type (2019-2024)
Figure 38. Americas Choroidal Neovascularization Sales Market Share by Application (2019-2024)
Figure 39. United States Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Choroidal Neovascularization Sales Market Share by Region in 2023
Figure 44. APAC Choroidal Neovascularization Revenue Market Share by Regions in 2023
Figure 45. APAC Choroidal Neovascularization Sales Market Share by Type (2019-2024)
Figure 46. APAC Choroidal Neovascularization Sales Market Share by Application (2019-2024)
Figure 47. China Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Choroidal Neovascularization Sales Market Share by Country in 2023
Figure 55. Europe Choroidal Neovascularization Revenue Market Share by Country in 2023
Figure 56. Europe Choroidal Neovascularization Sales Market Share by Type (2019-2024)
Figure 57. Europe Choroidal Neovascularization Sales Market Share by Application (2019-2024)
Figure 58. Germany Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Choroidal Neovascularization Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Choroidal Neovascularization Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Choroidal Neovascularization Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Choroidal Neovascularization Sales Market Share by Application (2019-2024)
Figure 67. Egypt Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Choroidal Neovascularization in 2023
Figure 73. Manufacturing Process Analysis of Choroidal Neovascularization
Figure 74. Industry Chain Structure of Choroidal Neovascularization
Figure 75. Channels of Distribution
Figure 76. Global Choroidal Neovascularization Sales Market Forecast by Region (2025-2030)
Figure 77. Global Choroidal Neovascularization Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Choroidal Neovascularization Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Choroidal Neovascularization Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Choroidal Neovascularization Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Choroidal Neovascularization Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Choroidal Neovascularization
Figure 2. Choroidal Neovascularization Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Choroidal Neovascularization Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Choroidal Neovascularization Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Choroidal Neovascularization Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Intravenous
Figure 10. Product Picture of Intravitreal
Figure 11. Global Choroidal Neovascularization Sales Market Share by Type in 2023
Figure 12. Global Choroidal Neovascularization Revenue Market Share by Type (2019-2024)
Figure 13. Choroidal Neovascularization Consumed in Extreme Myopia
Figure 14. Global Choroidal Neovascularization Market: Extreme Myopia (2019-2024) & (K Units)
Figure 15. Choroidal Neovascularization Consumed in Malignant Myopic Degeneration
Figure 16. Global Choroidal Neovascularization Market: Malignant Myopic Degeneration (2019-2024) & (K Units)
Figure 17. Choroidal Neovascularization Consumed in Age-Related Developments
Figure 18. Global Choroidal Neovascularization Market: Age-Related Developments (2019-2024) & (K Units)
Figure 19. Global Choroidal Neovascularization Sales Market Share by Application (2023)
Figure 20. Global Choroidal Neovascularization Revenue Market Share by Application in 2023
Figure 21. Choroidal Neovascularization Sales Market by Company in 2023 (K Units)
Figure 22. Global Choroidal Neovascularization Sales Market Share by Company in 2023
Figure 23. Choroidal Neovascularization Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Choroidal Neovascularization Revenue Market Share by Company in 2023
Figure 25. Global Choroidal Neovascularization Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Choroidal Neovascularization Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Choroidal Neovascularization Sales 2019-2024 (K Units)
Figure 28. Americas Choroidal Neovascularization Revenue 2019-2024 ($ Millions)
Figure 29. APAC Choroidal Neovascularization Sales 2019-2024 (K Units)
Figure 30. APAC Choroidal Neovascularization Revenue 2019-2024 ($ Millions)
Figure 31. Europe Choroidal Neovascularization Sales 2019-2024 (K Units)
Figure 32. Europe Choroidal Neovascularization Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Choroidal Neovascularization Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Choroidal Neovascularization Revenue 2019-2024 ($ Millions)
Figure 35. Americas Choroidal Neovascularization Sales Market Share by Country in 2023
Figure 36. Americas Choroidal Neovascularization Revenue Market Share by Country in 2023
Figure 37. Americas Choroidal Neovascularization Sales Market Share by Type (2019-2024)
Figure 38. Americas Choroidal Neovascularization Sales Market Share by Application (2019-2024)
Figure 39. United States Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Choroidal Neovascularization Sales Market Share by Region in 2023
Figure 44. APAC Choroidal Neovascularization Revenue Market Share by Regions in 2023
Figure 45. APAC Choroidal Neovascularization Sales Market Share by Type (2019-2024)
Figure 46. APAC Choroidal Neovascularization Sales Market Share by Application (2019-2024)
Figure 47. China Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Choroidal Neovascularization Sales Market Share by Country in 2023
Figure 55. Europe Choroidal Neovascularization Revenue Market Share by Country in 2023
Figure 56. Europe Choroidal Neovascularization Sales Market Share by Type (2019-2024)
Figure 57. Europe Choroidal Neovascularization Sales Market Share by Application (2019-2024)
Figure 58. Germany Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Choroidal Neovascularization Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Choroidal Neovascularization Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Choroidal Neovascularization Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Choroidal Neovascularization Sales Market Share by Application (2019-2024)
Figure 67. Egypt Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Choroidal Neovascularization Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Choroidal Neovascularization in 2023
Figure 73. Manufacturing Process Analysis of Choroidal Neovascularization
Figure 74. Industry Chain Structure of Choroidal Neovascularization
Figure 75. Channels of Distribution
Figure 76. Global Choroidal Neovascularization Sales Market Forecast by Region (2025-2030)
Figure 77. Global Choroidal Neovascularization Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Choroidal Neovascularization Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Choroidal Neovascularization Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Choroidal Neovascularization Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Choroidal Neovascularization Revenue Market Share Forecast by Application (2025-2030)
More Publications
Global Medical Operating Table Market Growth 2024-2030
US$ 3,660.00
September 2024
138 pages
Global Liver Surgery and Neurosurgery Electrosurgical Units (ESUs) Market Growth 2025-2031
US$ 3,660.00
January 2025
111 pages
Global Biomedical Waste Management Services Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
February 2023
104 pages
Global Whole Genome Sequencing (WGS) Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
107 pages
